Events2Join

New therapies for follicular lymphoma on the horizon


New therapies for follicular lymphoma on the horizon

Recently approved targeted and immunotherapy drugs are helping patients diagnosed with follicular lymphoma live longer.

New Treatment Results for Follicular Lymphoma Clinical Trial ...

A clinical trial of the targeted therapy mosunetuzumab (Lunsumio) has found this drug may help patients with follicular lymphoma avoid ...

Combining New Therapies and MRD Approaches Across Lymphomas

Exciting developments in follicular lymphoma treatment are on the horizon, with ongoing trials exploring the combination of bispecific ...

Advances in Lymphoma Research - NCI

Use of this new drug may help older patients avoid what had been the standard treatment with an especially toxic chemotherapy drug. Clinical ...

Update on Follicular Lymphoma - YouTube

The Lymphoma Research Foundation is the nation's largest non-profit organization devoted to funding innovative research and providing people ...

Current and future therapies for follicular lymphoma

Obinutuzumab-based treatment in FL has shown better PFS rates and similar ORRs compared with rituximab-based treatment; however, rates of AEs, ...

Bispecific Antibody Therapies for Lymphoma - Dana-Farber

Three bispecific antibody therapies have been FDA approved with more on the horizon. These are exciting new medicines that rally the immune system in a ...

Follicular Lymphoma: Understanding Your Treatment Options

Radioimmunotherapy. This treatment approach combines radiation with anti-CD20 antibodies. The IV medication is radioactive so that when the lab- ...

How Will New Immunotherapies Fit Into the Treatment Landscape of ...

Future directions for follicular lymphoma treatments include potential use earlier in treatment or as combination therapy, ...

Achieving the Cure of Follicular Lymphoma: is it Time to Finalize ...

Among VLRs after front-line treatment (n=71), 31 patients (43.6%) received immune-chemotherapy (mostly R-CHOP), 22 (31%) chemotherapy alone, 2 ( ...

What New Lymphoma Treatment Options Are On the Horizon?

Comments1 · Non-Hodgkin Lymphoma: First Symptoms, Diagnosis & the LATEST Treatments | The Patient Story · Hodgkin Lymphoma: What are My Treatment ...

New horizons in R/R follicular lymphoma: Focus on risk stratification ...

There is no upper age limit on who can receive CAR T-cell therapy3 and available evidence suggests it can be safely administered to older patients.4 In clinical ...

Investigators Set Sights on Curative Approaches for Follicular ...

During a recent OncLive Peer Exchange®, a panel of lymphoma experts discussed 2 recently approved treatments that are providing hope to patients ...

Highlighting Mitigation Strategies for Toxicity in Follicular Lymphoma

We've overcome a lot of the challenges in treatingpatients with follicular lymphoma. We conventionally had chemotherapy-based treatments only, ...

Evolving therapeutic landscape in follicular lymphoma

Ever since the introduction of rituximab that revolutionized the treatment of B cell NHL, new antibody therapies, including ofatumumab, ...

The Evolving Lymphoma Treatment Landscape - OncLive

Similar trends are occurring in mantle cell lymphoma, with Bruton tyrosine kinase inhibitors like ibrutinib now incorporated frontline for ...

FDA Approves New Immunotherapy for Follicular Lymphoma | Moffitt

The US Food and Drug Administration has approved epcoritamab, an innovative immunotherapy for patients with relapsed or refractory follicular lymphoma.

Follicular Lymphoma: Stages, Symptoms, Treatment & Prognosis

Follicular lymphoma is a very slow-growing cancer that may appear in your lymph nodes, your bone marrow and other organs.

Combination Therapies & Exciting News in Follicular Lymphoma

Follicular lymphoma treatment options are changing fast! ASH 2020 brings exciting news of combination therapies, CAR T-cell therapy ...

Combining New Therapies and MRD Approaches Across Lymphomas

Exciting developments in follicular lymphoma treatment are on the horizon, with ongoing trials exploring the combination of bispecific ...